Bristol-Myers Squibb

BMY · NYSE

$61.68+$2.85 (+4.84%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $58.83

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 32,500 full-time employees. The company is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Employees: 32,500
Headquarters: Princeton, New Jersey
Listed: Mar 17, 1980
Sector: Health Care
Industry: Pharmaceuticals
Website: bms.com

Leadership

Bristol-Myers Squibb executives
Name	Title	Since	Age
Christopher Boerner	—	2018	54
David Elkins	—	—	57
Benjamin Hickey	—	—	50
Lynelle Hoch	—	—	52
Amanda Poole	—	—	50
Greg Meyers	—	—	52
Cari Gallman	—	—	45
Adam Lenkowsky	—	—	52
Robert Plenge	—	—	54
Karin Shanahan	—	—	60
Phil Holzer	—	—	49
Theodore Samuels	—	—	70
Peter Arduini	—	—	60
Deepak Bhatt	—	—	57
Julia Haller	—	—	70
Michael McMullen	—	—	64
Manuel Medina	—	—	57
Paula Price	—	—	63
Derica Rice	—	—	60
Karen Vousden	—	—	67
Phyllis Yale	—	—	67

Revenue by product and region

Fiscal year ended Dec 31, 2025: $48.19B total revenue

By product

Alliance and other revenues$1.44B3.0%
Net product sales$178.00M0.4%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Bristol-Myers Squibb suppliers and customers
Company	Relationship	Country	Correlation
AbbVie ABBV	Supplier and customer	—	0.75
Sanofi SAN.PA	Supplier and customer	—	0.74
Alexandria Real Estate ARE	Supplier	—	0.73
Berkshire Hathaway B BRK.B	Supplier and customer	—	0.73
Roche Holding ROG.SW	Supplier and customer	—	0.73
Veolia Environnement VIE.PA	Supplier	—	0.72
McKesson Corporation MCK	Customer	—	0.71
Johnson & Johnson JNJ	Supplier and customer	—	0.70
Oxford BioMedica OXB.L	Supplier and customer	—	0.70
AmerisourceBergen Corporation ABC	Customer	—	0.69

Similar companies

Companies in the same industry as Bristol-Myers Squibb

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.